| answer text |
<p> </p><p>Prior to the establishment of the National Institute for Health Research
(NIHR) in April 2006, the main part of the Department's total health research expenditure
was devolved to and managed by national health service organisations. From April 2006
to March 2009, transitional research funding was allocated to these organisations
at reducing levels. The organisations have accounted for their use of the allocations
they have received from the Department in an annual research and development report.
The reports identify total, aggregated expenditure on national priority areas but
do not provide details of spend on research into specific diseases including motor
neurone disease (MND).</p><p> </p><p> </p><p> </p><p>Expenditure on MND research by
the NIHR from 2009-10 through research programmes, research centres and units, and
research fellowships is shown in the following table.</p><p> </p><p> </p><p> </p><p><em>£
million</em></p><p> </p><table><tbody><tr><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr></tbody></table><p>
</p><p> </p><p> </p><p>Total spend by the NIHR on MND research is higher than this
because expenditure by the NIHR Clinical Research Network (CRN) on this topic cannot
be disaggregated from total CRN expenditure.</p><p> </p><p> </p><p> </p><p>My Rt.
hon. Friend the Secretary of State for Health (Jeremy Hunt) has had no discussions
on funding for MND research with the Scottish Government Cabinet Secretary for Health
and Wellbeing.</p><p> </p>
|
|
